CONMED Corporation has grown revenue 6.4% a year over three years and 7.0% a year over five, with earnings per share compounding at −14%. Revenue growth, 3-year annual rate: +6.4% (Medical Devices median +12%). Revenue growth, 5-year rate: +7.0%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −14%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 17, FY2009 to FY2025, as filed.

CNMDCONMED Corporation

Healthcare

$44.43-11% 1Y

$44.43

$32.1152 weeks$51.88

Is it growing?

Watch

Growth is fading: earnings down −48% year on year and operating margin narrowing (−5.0 points).

2 to watch, 1 neutral

Revenue trend+3% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +7% a year.

Earnings trend−48% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−5.0 points operating

Trailing-twelve-month operating margin, 8.0% now against 13.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CNMD growing?

CONMED Corporation has grown revenue 6.4% a year over three years and 7.0% a year over five, with earnings per share compounding at −14%.

+6.4%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +7.0%
Revenue growth, 5-year rate · +6.4% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −14%
Earnings per share, 3-year rate · revenue +6.4% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed